Literature DB >> 3293793

Immunochemical and immunocytochemical characterization of a novel monoclonal antibody recognizing a 140 kDa protein in cerebral pericytes of the rat.

D Krause1, B Vatter, R Dermietzel.   

Abstract

A monoclonal antibody that recognizes a 140 kDa peripheral plasma membrane protein in pericytes of nervous tissues of the rat is described. Microvessels of brain cortex and perineurium of peripheral nerves are shown to react positively to this antibody. The antigen is absent in brain regions that lack a blood-brain barrier, i.e., choroid plexuses and area postrema. Antigen expression starts as early as day 18 of embryonic development. By means of immunoelectron microscopy the 140 kDa antigen was detected as clusters along the entire circumference of cerebral pericytes. The same antigenic determinant is also expressed in apical domains of plasma membranes of a variety of transporting epithelia, such as hepatocytes, enterocytes of the small intestine, and epithelial cells of proximal tubules of the kidney. We postulate the 140 kDa protein as being a constituent of the pericytes involved in regulative functions of the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3293793     DOI: 10.1007/bf00216641

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  37 in total

1.  Polarity of the blood-brain barrier: neutral amino acid transport into isolated brain capillaries.

Authors:  A L Betz; G W Goldstein
Journal:  Science       Date:  1978-10-13       Impact factor: 47.728

2.  Developing brain produces an angiogenesis factor.

Authors:  W Risau
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  The reaction of pericytes of the central nervous system to exogenous protein.

Authors:  P A Cancilla; R N Baker; P S Pollock; S P Frommes
Journal:  Lab Invest       Date:  1972-04       Impact factor: 5.662

4.  Transport of proteins across normal cerebral arterioles.

Authors:  E Westergaard; M W Brightman
Journal:  J Comp Neurol       Date:  1973-11-01       Impact factor: 3.215

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Antibodies to blood-brain barrier bind selectively to brain capillary endothelial lateral membranes and to a 46K protein.

Authors:  W M Pardridge; J Yang; J Eisenberg; L J Mietus
Journal:  J Cereb Blood Flow Metab       Date:  1986-04       Impact factor: 6.200

7.  Polarity of the blood-brain barrier: distribution of enzymes between the luminal and antiluminal membranes of brain capillary endothelial cells.

Authors:  A L Betz; J A Firth; G W Goldstein
Journal:  Brain Res       Date:  1980-06-16       Impact factor: 3.252

8.  A method for the preparation of cerebral blood vessels.

Authors:  K Grocki; R Dermietzel
Journal:  J Microsc       Date:  1984-01       Impact factor: 1.758

9.  The microvascular pattern and perivascular linings of the area postrema. A combined freeze-etching and ultrathin section study.

Authors:  R Dermietzel; A G Leibstein
Journal:  Cell Tissue Res       Date:  1978-01-09       Impact factor: 5.249

Review 10.  Morphology of blood-brain interfaces.

Authors:  M W Brightman
Journal:  Exp Eye Res       Date:  1977       Impact factor: 3.467

View more
  3 in total

Review 1.  Blood-brain barrier and new approaches to brain drug delivery.

Authors:  W M Pardridge; R J Boado; K L Black; P A Cancilla
Journal:  West J Med       Date:  1992-03

Review 2.  The versatility of microvascular pericytes: from mesenchyme to smooth muscle?

Authors:  V Nehls; D Drenckhahn
Journal:  Histochemistry       Date:  1993-01

3.  Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds.

Authors:  R O Schlingemann; F J Rietveld; R M de Waal; S Ferrone; D J Ruiter
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.